| FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells N Javidi-Sharifi, J Martinez, I English, SK Joshi, R Scopim-Ribeiro, ... Elife 8, e40033, 2019 | 67 | 2019 |
| Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcoma HF Zhang, CS Hughes, W Li, JZ He, D Surdez, AM El-Naggar, H Cheng, ... Cancer discovery 11 (11), 2884-2903, 2021 | 53 | 2021 |
| Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 P de Melo Campos, JA Machado-Neto, R Scopim-Ribeiro, V Visconte, ... Leukemia research 38 (10), 1245-1251, 2014 | 52 | 2014 |
| Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis JA Machado-Neto, BA Fenerich, APN Rodrigues Alves, JC Fernandes, ... Clinics 73, e566s, 2018 | 42 | 2018 |
| ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells JA Machado-Neto, M Lazarini, P Favaro, P de Melo Campos, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (3), 583-593, 2015 | 36 | 2015 |
| NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells BA Fenerich, JC Fernandes, APN Rodrigues Alves, JL Coelho-Silva, ... Signal transduction and targeted therapy 5 (1), 5, 2020 | 30 | 2020 |
| IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms P de Melo Campos, JA Machado-Neto, CA Eide, SL Savage, ... Oncotarget 7 (6), 6948, 2016 | 29 | 2016 |
| Ten‐Eleven‐Translocation 2 (TET 2) is downregulated in myelodysplastic syndromes R Scopim‐Ribeiro, JA Machado‐Neto, PM Campos, CAM Silva, P Favaro, ... European Journal of Haematology 94 (5), 413-418, 2015 | 26 | 2015 |
| Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms JA Machado-Neto, BA Fenerich, R Scopim-Ribeiro, CA Eide, ... Cell death & disease 9 (3), 311, 2018 | 24 | 2018 |
| IRS1/β‐Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells JC Fernandes, APN Rodrigues Alves, JA Machado‐Neto, ... Journal of Cellular Biochemistry 118 (7), 1774-1781, 2017 | 22 | 2017 |
| Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms R Scopim-Ribeiro, JA Machado-Neto, P de Melo Campos, FS Niemann, ... Diagnostic pathology 11, 1-5, 2016 | 18 | 2016 |
| Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells JA Machado-Neto, APNR Alves, JC Fernandes, JL Coelho-Silva, ... Heliyon 3 (9), 2017 | 14 | 2017 |
| NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia R Scopim-Ribeiro, JA Machado-Neto, CA Eide, JL Coelho-Silva, ... Investigational New Drugs 39, 736-746, 2021 | 10 | 2021 |
| NSG Mice Facilitate ex vivo Characterization of Ewing Sarcoma Lung Metastasis Using the PuMA Model R Scopim-Ribeiro, MM Lizardo, HF Zhang, AC Dhez, CS Hughes, ... Frontiers in Oncology 11, 645757, 2021 | 6 | 2021 |
| Increased levels of cyclin D1 negatively impacts on acute lymphoblastic leukemia overall survival JC Fernandes, APN Rodrigues Alves, JL Coelho-Silva, R Scopim-Ribeiro, ... Applied Cancer Research 38, 1-4, 2018 | 3 | 2018 |
| Correction: FGF2-FGFR1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells N Javidi-Sharifi, J Martinez, I English, SK Joshi, R Scopim-Ribeiro, ... Elife 8, e47174, 2019 | 2 | 2019 |
| Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412 PDM Campos, JA Machado-Neto, ASS Duarte, R Scopim-Ribeiro, ... Blood 122 (21), 5267, 2013 | 2 | 2013 |
| TET2 is upregulated during erythroid differentiation of CD34+ cells from healthy donors and myelodysplastic syndrome patients R Scopim-Ribeiro, JA Machado-Neto, A da Silva Santos Duarte, FF Costa, ... Applied Cancer Research 37, 1-4, 2017 | 1 | 2017 |
| Pharmacological IRS1/2 Inhibition Reduces Cell Viability in BCR-ABL1 Positive Cells R Scopim-Ribeiro, JA Machado-Neto, P de Melo Campos, ASS Duarte, ... Blood 126 (23), 2772, 2015 | 1 | 2015 |
| Targeting Ewing Sarcoma By Genetically and Epigenetically Modified Ex-Vivo Expanded NK Cells in Combination with NKTR-255 and Dinutuximab W Luo, HF Zhang, W Li, H Hoang, Y Chu, R Gandhi, W Chemnitz, J Ayello, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
